What is RCEL's health score?

AVITA Medical, Inc. (RCEL) has a TradeApes health score of 41 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RCEL's estimated fair value?

Based on our 5-year discounted cash flow model, AVITA Medical, Inc.'s estimated fair value is $3.75 per share, representing a -10.4% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is RCEL undervalued or overvalued?

Our model currently rates RCEL as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RCEL... Refresh in a moment for the full analysis.

AVITA Medical, Inc. (RCEL)

Healthcare Fair Value low weak

$4.18

Updated: 2026-06-06

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

60 Healthy

Relative Value

40 Weak

Capital Allocation

30 Weak

Risk

50 Mixed

Est. Fair Value $3.75

DCF Upside -10.4%

Sector Rank #587 of 6770

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.